
    
      The primary purpose of this pilot study is to determine the feasibility of the Noona
      Healthcare Mobile PRO Application to describe oncology patient engagement using a web-based
      symptom self-monitoring instrument. Additionally, the studyy will dentify side effects as
      well as long term or chronic adverse events during and following cancer therapy based on the
      United States (US) National Cancer Institute (NCI) Patient Reported Outcomes Common
      Terminology Criteria for Adverse Events (PRO-CTCAE), and identify patients to participate in
      future long-term Quality of Life studies following cancer therapy.

      The study is not intended to compare outcomes between groups receiving different therapies.
    
  